Dyadic International Inc (DYAI) stock
DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.32−0.00 (-1.25%)
Close on Nov 17, 2026Market cap $11.51MP/E –Yield –
Dyadic International total assets
Total assets on the balance sheet at the end of each period.
Dyadic International's total assets was $7.93M at Sep 30, 2026. For fiscal 2025 it was $9.95M, up 0.2% from the year before. The highest annual figure on record is $50.74M in fiscal 2017.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.95M | +0.2% |
| FY2024 | Dec 31, 2024 | $9.93M | +20.8% |
| FY2023 | Dec 31, 2023 | $8.22M | -40.1% |
| FY2022 | Dec 31, 2022 | $13.71M | -35.6% |
| FY2021 | Dec 31, 2021 | $21.30M | -29.2% |
| FY2020 | Dec 31, 2020 | $30.07M | -19.7% |
| FY2019 | Dec 31, 2019 | $37.45M | -13.5% |
| FY2018 | Dec 31, 2018 | $43.30M | -14.7% |
| FY2017 | Dec 31, 2017 | $50.74M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.93M | -32.0% |
| Q2 FY2026 | Jun 30, 2026 | $6.54M | -19.7% |
| Q1 FY2026 | Mar 31, 2026 | $7.81M | -1.1% |
| Q4 FY2025 | Dec 31, 2025 | $9.95M | +0.2% |
| Q3 FY2025 | Sep 30, 2025 | $11.67M | +8.0% |
| Q2 FY2025 | Jun 30, 2025 | $8.14M | -23.4% |
| Q1 FY2025 | Mar 31, 2025 | $7.89M | -37.7% |
| Q4 FY2024 | Dec 31, 2024 | $9.93M | +20.8% |
| Q3 FY2024 | Sep 30, 2024 | $10.81M | +16.7% |
| Q2 FY2024 | Jun 30, 2024 | $10.63M | -4.0% |
| Q1 FY2024 | Mar 31, 2024 | $12.68M | -1.0% |
| Q4 FY2023 | Dec 31, 2023 | $8.22M | -40.1% |
| Q3 FY2023 | Sep 30, 2023 | $9.26M | -39.2% |
| Q2 FY2023 | Jun 30, 2023 | $11.07M | -35.7% |
| Q1 FY2023 | Mar 31, 2023 | $12.81M | -99.9% |
| Q4 FY2022 | Dec 31, 2022 | $13.71M | -35.6% |
| Q3 FY2022 | Sep 30, 2022 | $15.22M | -36.2% |
| Q2 FY2022 | Jun 30, 2022 | $17.22M | -34.9% |
| Q1 FY2022 | Mar 31, 2022 | $18.53B | +65419.1% |
| Q4 FY2021 | Dec 31, 2021 | $21.30M | -29.2% |
| Q3 FY2021 | Sep 30, 2021 | $23.86M | -24.8% |
| Q2 FY2021 | Jun 30, 2021 | $26.45M | -21.6% |
| Q1 FY2021 | Mar 31, 2021 | $28.28M | -20.1% |
| Q4 FY2020 | Dec 31, 2020 | $30.07M | -19.7% |
| Q3 FY2020 | Sep 30, 2020 | $31.75M | -17.6% |
| Q2 FY2020 | Jun 30, 2020 | $33.73M | -15.8% |
| Q1 FY2020 | Mar 31, 2020 | $35.39M | -15.5% |
| Q4 FY2019 | Dec 31, 2019 | $37.45M | -13.5% |
| Q3 FY2019 | Sep 30, 2019 | $38.52M | -24.1% |
| Q2 FY2019 | Jun 30, 2019 | $40.07M | – |
| Q1 FY2019 | Mar 31, 2019 | $41.86M | – |
| Q4 FY2018 | Dec 31, 2018 | $43.30M | – |
| Q4 FY2017 | Dec 31, 2017 | $50.74M | – |
See a number that looks wrong?